Cargando…

Remyelination in multiple sclerosis from the miRNA perspective

Remyelination relies on the repair of damaged myelin sheaths, involving microglia cells, oligodendrocyte precursor cells (OPCs), and mature oligodendrocytes. This process drives the pathophysiology of autoimmune chronic disease of the central nervous system (CNS), multiple sclerosis (MS), leading to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maciak, Karina, Dziedzic, Angela, Saluk, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270307/ https://www.ncbi.nlm.nih.gov/pubmed/37333618 http://dx.doi.org/10.3389/fnmol.2023.1199313

Ejemplares similares

miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review
por: Maciak, Karina, et al.
Publicado: (2021)

Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review
por: Pogoda-Wesołowska, Aleksandra, et al.
Publicado: (2023)

Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
por: Packer, Davin, et al.
Publicado: (2023)

Remyelination Therapy in Multiple Sclerosis
por: Harlow, Danielle E., et al.
Publicado: (2015)

Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review
por: Pietrasik, Sylwia, et al.
Publicado: (2021)

Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic’s Disease) and Multiple Sclerosis—A Review
por: Maciak, Karina, et al.
Publicado: (2021)

Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment
por: Dziedzic, Angela, et al.
Publicado: (2022)

Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
por: Gharagozloo, Marjan, et al.
Publicado: (2022)

Screening Analysis of Platelet miRNA Profile Revealed miR-142-3p as a Potential Biomarker in Modeling the Risk of Acute Coronary Syndrome
por: Szelenberger, Rafał, et al.
Publicado: (2021)

Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis
por: Saluk-Bijak, Joanna, et al.
Publicado: (2019)

Remyelination In Multiple Sclerosis
por: Chari, Divya M.
Publicado: (2007)

Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
por: Rashidbenam, Zahra, et al.
Publicado: (2023)

In vivo MRI is sensitive to remyelination in a nonhuman primate model of multiple sclerosis
por: Donadieu, Maxime, et al.
Publicado: (2023)

Editorial: The molecular mechanisms and potential drug targets for remyelination and neuroregeneration
por: Rutkowska, Aleksandra, et al.
Publicado: (2023)

Serum miRNA modulations indicate changes in retinal morphology
por: Aggio-Bruce, Riemke, et al.
Publicado: (2023)

Promoting remyelination in multiple sclerosis
por: Cunniffe, Nick, et al.
Publicado: (2019)

Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration
por: Devier, Deidre J., et al.
Publicado: (2015)

Inferring miRNA sponge modules across major neuropsychiatric disorders
por: Balasubramanian, Rami, et al.
Publicado: (2022)

Dietary Supplementation With Acer truncatum Oil Promotes Remyelination in a Mouse Model of Multiple Sclerosis
por: Xue, Yuhuan, et al.
Publicado: (2022)

A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis
por: Miller, Elzbieta Dorota, et al.
Publicado: (2019)

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021)

The GPR17 Receptor—A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)

Electroacupuncture alleviates perioperative hypothalamus-pituitary-adrenal axis dysfunction via circRNA-miRNA-mRNA networks
por: Wang, Yu, et al.
Publicado: (2023)

Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature
por: Redenšek Trampuž, Sara, et al.
Publicado: (2023)

RNA-binding proteins as a common ground for neurodegeneration and inflammation in amyotrophic lateral sclerosis and multiple sclerosis
por: Acosta-Galeana, Isabel, et al.
Publicado: (2023)

Platelets miRNA as a Prediction Marker of Thrombotic Episodes
por: Bijak, Michal, et al.
Publicado: (2016)

Role of Multifocal Visually Evoked Potential as a Biomarker of Demyelination, Spontaneous Remyelination, and Myelin Repair in Multiple Sclerosis
por: Klistorner, Alexandr, et al.
Publicado: (2021)

Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis
por: Zhao, Xinda, et al.
Publicado: (2023)

Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
por: Podbielska, Maria, et al.
Publicado: (2013)

Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014)

Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Jolanda Münzel, E., et al.
Publicado: (2013)

Imaging outcomes for trials of remyelination in multiple sclerosis
por: Mallik, Shahrukh, et al.
Publicado: (2014)

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis
por: You, Yuyi, et al.
Publicado: (2018)

The Molecular Basis for Remyelination Failure in Multiple Sclerosis
por: Gruchot, Joel, et al.
Publicado: (2019)

Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination
por: Correale, Jorge, et al.
Publicado: (2022)

Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model
por: Leo, Heinig, et al.
Publicado: (2022)

Molecule of the month: miRNA and Multiple Sclerosis
por: Shapshak, Paul
Publicado: (2013)

Editorial: MiRNAs as pivotal components of ncRNA networks associated with CNS injuries and neurodegeneration, and their therapeutic potential
por: Campos-Melo, Danae, et al.
Publicado: (2023)

The Molecular Aspects of Disturbed Platelet Activation through ADP/P2Y(12) Pathway in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jb8naev0cqo8fl2ktuggk061li